<DOC>
	<DOCNO>NCT00519194</DOCNO>
	<brief_summary>The purpose study test safety efficacy Epicor LP Cardiac Ablation System treat permanent atrial fibrillation concomitant open chest and/or open heart surgery one following procedure : mitral valve repair replacement , aortic valve repair replacement , tricuspid valve repair replacement , coronary artery bypass surgery patent foramen ovale ( PFO closure ) .</brief_summary>
	<brief_title>CONcomitant eValuation Epicor Left atRial Therapy AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1880 year old Permanent AF define continuous AF last &gt; one year OR non selfterminating AF last &gt; seven day one year least one fail DC cardioversion Have concomitant indication open chest and/or open heart surgery one following : mitral valve repair replacement , aortic valve repair replacement , tricuspid valve repair replacement , patent foramen ovale ( PFO ) closure coronary artery bypass surgery Be able take anticoagulation therapy Be able fulfill study requirement Be able sign studyspecific inform consent Presence previously implant device adjacent treatment target area may alter delivery therapy Prior cardiac surgery Presence active endocarditis , local system infection Presence advance heart failure ( NYHA class &gt; II , &amp; LVEF &lt; 20 % ) Intraaortic balloon pump , IV inotropes vasoactive agent within 30 day Emergent cardiac surgery due acute MI acute mitral regurgitation Life expectancy &lt; 1 year Major progressive noncardiac disease Presence leave atrial thrombus Left atrial diameter &gt; 6.0 cm Any condition prevents investigator safely performing procedure Positive urine serum pregnancy test Prior leave atrial ablation Currently participate another clinical research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Arrhythmia</keyword>
	<keyword>Atrial Fibrillation</keyword>
</DOC>